Research Article
A Novel Bimodal Imaging Agent Targeting HER2 Molecule of Breast Cancer
Figure 4
Stability of IR783-NBs-Affibody. (a) The changes of IR783-NBs-Affibody’s size distribution over 20 min. , obviously different from ones at 1 min. (b) The changes of IR783-NBs-Affibody’s concentration over 20 min. , obviously different from ones at 1 min.
(a) |
(b) |